Need Help? (888) 742-5060

In The News:

Thermo Fisher to Acquire Brammer Bio

Thermo Fisher Scientific Inc. (NYSE: TMO), Waltham, MA, has agreed to acquire Brammer Bio for $1.7 billion. The acquisition would expand the lab-equipment company’s presence in the field of gene therapy.

Brammer Bio, owned by private-equity firm Ampersand Capital Partners, provides pharmaceutical companies developing gene therapies and gene-modified cell therapies with outsourced research and drug making services.

Brammer Bio was formed in 2016 through the merger of Brammer Biopharmaceuticals and Florida Biologix.

© 2019 Gale Media, Inc.

Please do not reprint MDM's content on your website without MDM's express permission as it is copyrighted material. To gain permission, email us, or call 1-888-742-5060. For information on PDF or print reprints, visit MDM welcomes inbound links from your site. Please cite Modern Distribution Management.

2018-top-distributors-listThe 2018 Top Distributors List

This free PDF includes lists of top distribution companies across 14 sectors.

You will also receive MDM Update, our daily distribution e-newsletter & other distribution-focused content.

Download the Free PDF now >>

MDM-UpdateMDM Update: Daily Newsletter 

Sign up to read the best source for news & trends in wholesale distribution, MDM Update. Delivered daily to your inbox. 

Sign-up for MDM Update >>

Partner Center